Thrilled to announce our new paper published in the June 1 2021 issue of the Journal of Clinical Investigation. Read about our findings on how FUT1 mediates fucoyslation of membrane-bound proteins, including CD147, EGFR, ICAM-1 and EPHA2, to drive cancer stemness in a glucose-deprived HCC microenvironment. Congrats to Jane and the team! Link to full article here.
Ecstatic to have the opportunity to participate at the Keystone eSymposia on Cancer Stem Cells: Advances in Biology and Clinical Translation held May 19-21, 2021. Shared my group’s recent research progress on how the non-cellular components of the tumor microenvironment shapes cancer stemness in the liver; and learnt about the exciting new projects from others! Postdoc Lena and PhD student Huajian in the lab also shared their recent research findings in a short talk and poster abstract. Link to full program can be found here.
Our lab retreat was successfully held May 14-15 at HK Science Park’s InnoCell. The past year had been particularly challenging for everyone. It was a great opportunity to come together to share ideas, brainstorm, reflect, relax and socialize. I hope everyone enjoyed the time together. Thankful for my great team! #stayfocused #keeppushing
Our Research Assistant Professor Man Tong (Carol) gave a summary of her past and current work on novel therapeutic strategies to target dysregulated signaling pathways in HCC at the School of Biomedical Sciences RAP/PDF Seminar Series on January 27, 2021.
Our postdoc Tin Lok Wong (Eric) gave a seminar on his latest work on modeling liver cancer and therapy response using driver-dependent tumor organoids derived from primary mouse liver tumors at the School of Biomedical Sciences RAP/PDF Seminar Series on January 6, 2021.